Search research articles
Contact Us
Filters
Showing results (941-950 of 983) with videos related to
Page
of 99
Sort By:
Nature Cell Biology
|
October 17, 2017
Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche
Allison L Boyd, Jennifer C Reid, Kyle R Salci, et al.
BMJ Open
|
December 14, 2021
Functional recovery following hospitalisation of patients diagnosed with COVID-19: a protocol for a longitudinal cohort study
Julie C Reid, Andrew P Costa, MyLinh Duong, et al.
Journal of Cell Science
|
September 1, 2025
Histone deacetylase 7 mediates lipopolysaccharide-inducible mitochondrial fission in macrophages
Rishika Abrol, Syeda Farhana Afroz, James E B Curson, et al.
Gene Therapy
|
April 21, 2001
CL22 - a novel cationic peptide for efficient transfection of mammalian cells
A M Haines, A S Irvine, A Mountain, et al.
BMJ Open Respiratory Research
|
April 9, 2019
Multicentre pilot randomised clinical trial of early in-bed cycle ergometry with ventilated patients
Michelle E Kho, Alexander J Molloy, France J Clarke, et al.
Journal of Medicinal Chemistry
|
February 11, 2012
Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity
Steven M Johnson, Ryan C Murphy, Jennifer A Geiger, et al.
Journal of Medicinal Chemistry
|
October 2, 2008
Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant viruses
Thomas J Tucker, John T Sisko, Robert M Tynebor, et al.
Diabetes & Metabolism
|
June 4, 2015
The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?
J Harding, M Sooriyakumaran, K J Anstey, et al.
The Journal of Biological Chemistry
|
January 21, 2011
Structural basis for selective small molecule kinase inhibition of activated c-Met
Keith W Rickert, Sangita B Patel, Timothy J Allison, et al.
Chemistry & Biology
|
April 1, 1996
Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450
C N Hodge, P E Aldrich, L T Bacheler, et al.
Page
of 99
Search research articles
Search
Showing results (941-950 of 983) with videos related to
Sort By:
Page
of 99
Nature Cell Biology
|
October 17, 2017
Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche
Allison L Boyd, Jennifer C Reid, Kyle R Salci, et al.
BMJ Open
|
December 14, 2021
Functional recovery following hospitalisation of patients diagnosed with COVID-19: a protocol for a longitudinal cohort study
Julie C Reid, Andrew P Costa, MyLinh Duong, et al.
Journal of Cell Science
|
September 1, 2025
Histone deacetylase 7 mediates lipopolysaccharide-inducible mitochondrial fission in macrophages
Rishika Abrol, Syeda Farhana Afroz, James E B Curson, et al.
Gene Therapy
|
April 21, 2001
CL22 - a novel cationic peptide for efficient transfection of mammalian cells
A M Haines, A S Irvine, A Mountain, et al.
BMJ Open Respiratory Research
|
April 9, 2019
Multicentre pilot randomised clinical trial of early in-bed cycle ergometry with ventilated patients
Michelle E Kho, Alexander J Molloy, France J Clarke, et al.
Journal of Medicinal Chemistry
|
February 11, 2012
Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity
Steven M Johnson, Ryan C Murphy, Jennifer A Geiger, et al.
Journal of Medicinal Chemistry
|
October 2, 2008
Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant viruses
Thomas J Tucker, John T Sisko, Robert M Tynebor, et al.
Diabetes & Metabolism
|
June 4, 2015
The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?
J Harding, M Sooriyakumaran, K J Anstey, et al.
The Journal of Biological Chemistry
|
January 21, 2011
Structural basis for selective small molecule kinase inhibition of activated c-Met
Keith W Rickert, Sangita B Patel, Timothy J Allison, et al.
Chemistry & Biology
|
April 1, 1996
Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450
C N Hodge, P E Aldrich, L T Bacheler, et al.
Page
of 99